NCT04119453 2024-06-24
A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)
Elevar Therapeutics
Phase 2 Terminated
Clinical Trials
3 trialsNCT02942693 2018-09-28
Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma
Shanghai Proton and Heavy Ion Center
Phase 2 Unknown
NCT02775370 2018-09-26
A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Unknown